Use of a Mechanically Passive Rehabilitation Device in Vietnam: Impact on Upper Extremity Hemiparesis After Stroke

January 2, 2015 updated by: Janna, California State University, Northridge

Use of a Mechanically Passive Rehabilitation Device as a Training Tool in Vietnam: Impact on Upper Extremity Hemiparesis After Stroke

The goal of this project is to test a device (Zondervan et al, 2013) that can provide active assistance for arm training for people in Vietnam with severe to moderate stroke, but that is also simple and does not rely on powered actuators. The hypothesis is that individuals with a severe chronic stroke, who exercise with a mechanically passive rehabilitation device, will have improved arm movement ability without experiencing an increase in arm pain.

Study Overview

Status

Unknown

Intervention / Treatment

Detailed Description

A randomized control trial design will compare two arms, consisting of the Resonating Arm Exerciser (RAE) and standard Physical Therapy (PT), with each subject receiving both treatments. Randomization will be used to determine the order in which the subject receives each treatment; i.e. RAE followed by PT, or PT followed by RAE.

At the scheduled test period, the purpose and procedure of the study will be explained via a medical translator employed by the hospital. The subject will be asked to read and sign two copies of both the Bill of Rights and the Informed Consent Form. The researcher will retain one copy for the purpose of research records and the second copy will be given to the subject. Interview and score on the Mini Mental Status Exam will determine subject's inclusion, in order for participant's cognitive state to be intact and have the capability to follow directions, give consent, participate, and communicate directly or indirectly with translators to the investigators. Administration of the Upper Extremity-Fugl Meyer Assessment (UE-FMA) will be administered next for further subject eligibility. Any additional questions asked by the subject will be answered before any testing begins. Translators and researchers will be available to assist with survey administration and completion, with no maximum time allotted for each survey. Any subject who does not meet the inclusion criteria will be thanked and released from the study. Subjects who met the criteria, will continue with the Wong Baker Faces Pain Rating Scale (WBFRPS) and the Stroke Impact Scale (SIS) or SIS proxy version if the subject is unable to read and write independently.

INTERVENTION Simple random sampling will be used to allocate 30 eligible participants into either the treatment group or the control group. The treatment group will use the RAE for 3 weeks, whereas the control group will continue with existing physical therapy treatment of passive range of motion (PROM) and therapeutic exercise to their involved upper extremity by the hospital physical therapist. The treatment group will participate in supervised RAE group sessions of 45 minutes, three times a week, for a total of eight sessions for three consecutive weeks. During each treatment session, the affected upper extremity will be used to push on the lever of the RAE in the sagittal plane. Upon pushing and pulling on the lever, the wheelchair moves a total of 20 cm from a neutral position, which indicated a repetition counted by a programed iphone. Researchers continuously will monitor the treatment group to ensure compliance with the use of the RAE, refrain from compensatory trunk movement and address patient discomfort. After four sessions with the RAE, the elastic band connected to the device will be stretched to an increased length, in order to increase stiffness for continued use.

At the completion of three weeks, participants in the control and treatment group will perform the UE-FMA, SIS, WBFPRS as a post-treatment measurement. The continued presence of medical translators will be utilized for the UE-FMA and for any questions the participants might have during the SIS and WBFPRS. Following data collection, participants will switch groups. Subjects in the experimental group will become the control group and receive their normal physical therapy treatment by the hospital PT for an additional three weeks. The treatment group will participate in supervised RAE group sessions in increments of 45 minutes, three times a week, a total of eight sessions for three consecutive weeks. They will be supervised by two senior licensed physical therapists Hospital, who were trained by the researchers of this study. Their training will include the proper use of the RAE and data collection of outcome measures. Intra-rater and inter-rater reliability was established on the use of the UE-FMA, prior to data collection. At the conclusion of the six-week study, all participants will perform the UE-FMA, SIS, and WBFPRS. During the six-week duration of the study, an on-site medical professional and on-site translator will be present, to protect against medical complications and language barriers. Subjects will be able to refuse or drop out at any point of the study without repercussions and continue to receive uninterrupted medical care at the hospital.

Study Type

Interventional

Enrollment (Anticipated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 18 years or older
  • diagnosis of stoke more than six months post injury
  • patient in Da Nang, Vietnam
  • <35 out of 66 on the UE-FMA
  • ability to perform one complete repetition with the RAE
  • participants' willingness to refrain from additional rehabilitation for the upper extremities during the duration of the RAE portion of the study.

Exclusion Criteria:

  • < 24 out of 30 on the Mini-Mental State Examination (MMSE) (Mitrushina, 1991)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Resonating Arm Exerciser
The treatment group will participate in supervised Resonating Arm Exerciser (RAE) group sessions of 45 minutes, three times a week, for a total of eight sessions for three consecutive weeks. During each treatment session, the affected upper extremity will be used to push on the lever of the RAE in the sagittal plane. Upon pushing and pulling on the lever, the wheelchair moves a total of 20 cm from a neutral position, which indicated a repetition counted by a programed iphone.
Participants in the exercise group will exercise using the device for 8 exercise sessions for 45 minutes per session for 3 consecutive weeks.
No Intervention: Physical Therapy
The control group will continue with existing physical therapy treatment of passive range of motion (PROM) and therapeutic exercise to their involved upper extremity by the physical therapist.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Upper Extremity-Fugl Meyer Assessment (UE-FMA)
Time Frame: up to 6 weeks
The UE-FMA will assess sensorimotor performance of the volunteer's arm and takes 30-minutes to complete. This includes assessing reflex activity, volitional movement within synergy, volitional movement mixing synergies, volitional movement out of synergy, wrist movement, hand movement, coordination, sensation and proprioception (Fugl-Meyer, 1975). A score of < 35/66 indicated moderate to severe impairments, which will be used as a baseline measure.
up to 6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Stroke Impact Scale
Time Frame: Baseline, 3 weeks, 6 weeks
The SIS will be used to evaluate how stoke impacted the subject's health and life and takes 20-minutes to complete. A Vietnamese translated hard copy will be provided to the participants. A proxy version will be available in Vietnamese, in order for a caregiver or medical personnel to read the test to participants if they were unable to read or write. This survey consists of questions about physical problems, memory, mood, activities of daily living, and mobility during a 4-week timeframe (Vellone, 2014). A licensing agreement was obtained from KU Center For Technology Commercialization, Inc. for the use in our study. Christina Arana & Associates, Inc. performed Vietnamese translations with approval via a translation agreement from Mapi Research Trust in order to achieve harmonized and consistent language.
Baseline, 3 weeks, 6 weeks
Wong Baker Faces Pain Rating Scale
Time Frame: Baseline, 3 weeks, 6 weeks
WBFPRS will be used to assess the participants' arm pain with 0 being no pain, and 10 being the greatest pain possible and takes up to one minute to complete (Wong Baker, 2014). This scale has been translated into Vietnamese with corresponding faces to the written description of pain. Permission to use the scale was obtained from Wong-Baker Faces Foundation.
Baseline, 3 weeks, 6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Janna Beling, PhD, PT, California State University, Northridge

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2015

Primary Completion (Anticipated)

March 1, 2015

Study Completion (Anticipated)

March 1, 2015

Study Registration Dates

First Submitted

December 24, 2014

First Submitted That Met QC Criteria

December 29, 2014

First Posted (Estimate)

December 30, 2014

Study Record Updates

Last Update Posted (Estimate)

January 5, 2015

Last Update Submitted That Met QC Criteria

January 2, 2015

Last Verified

January 1, 2015

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cerebrovascular Accident

Clinical Trials on Resonating Arm Exerciser

3
Subscribe